- Home
- TGS vs ICUI Comparison
TGS vs ICUI Comparison
Compare TGS & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGS
- ICUI
- Stock Information
- Founded
- TGS 1992
- ICUI 1984
- Country
- TGS Argentina
- ICUI United States
- Employees
- TGS N/A
- ICUI N/A
- Industry
- TGS Natural Gas Distribution
- ICUI Medical/Dental Instruments
- Sector
- TGS Utilities
- ICUI Health Care
- Exchange
- TGS Nasdaq
- ICUI Nasdaq
- Market Cap
- TGS 4.1B
- ICUI 3.6B
- IPO Year
- TGS N/A
- ICUI 1992
- Fundamental
- Price
- TGS $26.90
- ICUI $140.38
- Analyst Decision
- TGS Strong Buy
- ICUI Buy
- Analyst Count
- TGS 1
- ICUI 4
- Target Price
- TGS $35.00
- ICUI $199.67
- AVG Volume (30 Days)
- TGS 249.3K
- ICUI 291.1K
- Earning Date
- TGS 05-05-2025
- ICUI 05-06-2025
- Dividend Yield
- TGS N/A
- ICUI N/A
- EPS Growth
- TGS 622.80
- ICUI N/A
- EPS
- TGS 0.48
- ICUI N/A
- Revenue
- TGS $1,183,090,354.00
- ICUI $2,382,046,000.00
- Revenue This Year
- TGS N/A
- ICUI $0.67
- Revenue Next Year
- TGS N/A
- ICUI $3.42
- P/E Ratio
- TGS $13.93
- ICUI N/A
- Revenue Growth
- TGS 23.70
- ICUI 5.44
- 52 Week Low
- TGS $14.16
- ICUI $93.36
- 52 Week High
- TGS $34.37
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- TGS 50.03
- ICUI 41.57
- Support Level
- TGS $25.90
- ICUI $135.42
- Resistance Level
- TGS $29.30
- ICUI $152.06
- Average True Range (ATR)
- TGS 1.40
- ICUI 5.87
- MACD
- TGS 0.06
- ICUI -0.29
- Stochastic Oscillator
- TGS 43.79
- ICUI 28.92
About TGS Transportadora de Gas del Sur SA TGS
Transportadora de Gas del Sur SA is a transporters of natural gas in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, and Production and Commercialization Liquids, Other Services, and Telecommunications. It generates maximum revenue from the Production and Commercialization of the Liquids segment. Geographically, it derives the majority of its revenue from Argentina.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.